CV Sciences (CVSI) Net Margin Growth (3y) (2016 - 2026)
CV Sciences (CVSI) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 651.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 651.00 |
| Mar 31, 2026 | -15,769.00 |
| Dec 31, 2025 | 6,465.00 |
| Sep 30, 2025 | 1,575.00 |
| Jun 30, 2025 | 7,914.00 |
| Mar 31, 2025 | 4,454.00 |
| Dec 31, 2024 | 16,627.00 |
| Sep 30, 2024 | -1,101.00 |
| Jun 30, 2024 | 5,407.00 |
| Mar 31, 2024 | 4,886.00 |
| Dec 31, 2023 | 15,590.00 |
| Sep 30, 2023 | 4,581.00 |
| Jun 30, 2023 | 5,427.00 |
| Mar 31, 2023 | 19,986.00 |
| Dec 31, 2022 | 1,189.00 |
| Sep 30, 2022 | -1,345.00 |
| Jun 30, 2022 | -9,364.00 |
| Mar 31, 2022 | 1,537.00 |
| Dec 31, 2021 | -19,864.00 |
| Sep 30, 2021 | -2,501.00 |